The Europe Surgical Power Tools Market would witness market growth of 4.3% CAGR during the forecast period (2022-2028).
The rise in major surgical procedures is blamed for the rise in the prevalence of chronic diseases like cancer, arthritis, and cardiovascular disorders. As a result, it is projected that this aspect will fuel the expansion of the market for surgical power tools. In addition, the demand for surgical power tools for surgical intervention is expected to grow as the prevalence of orthopedic illnesses like arthritis rises. This further stimulates the market's expansion. For instance, surgery may occasionally be needed to treat arthritis.
When arthritis has progressed to the point where the joint is significantly injured or when the pain is too intense for other treatments to be helpful, this is typically done. A broken joint may be replaced with an artificial one through surgery, or the joint's damaged tissue may be repaired. Furthermore, individuals with significant coronary artery disease are frequently advised to undergo coronary artery bypass graft (CABG) surgery (CAD).
In addition, aortic stenosis, congestive heart failure, and other heart conditions are also treated with it. Hence, it is projected that an increase in the prevalence of heart disorders will increase cardiovascular surgical procedures and further fuel the demand for surgical power tools. As a result, it is projected that this element will fuel market expansion.
Health care is expensive and provided in large quantities. According to the consensus statement on fractures and falls, which Public Health England and the National Falls Prevention Coordination Group published in January 2017, the overall cost of fragility fractures in the UK has been projected at £4.4 billion, with £1.1 billion going towards social care. Almost £2 billion of this sum is attributable to hip fractures. With almost 240,000 reports in acute hospitals or mental health trusts in Wales and England, falls in hospitals were the most frequent patient safety-related incident. This would stimulate the market for surgical power tools in Europe.
The Germany market dominated the Europe Surgical Power Tools Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $189.1 million by 2028. The UK market is anticipated to grow at a CAGR of 3.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.1% during (2022 - 2028).
Based on Technology, the market is segmented into Electric Operated, Battery Operated, and Pneumatic Operated. Based on Application, the market is segmented into Orthopedic Surgery, Cardiothoracic Surgery, Spine & Neuro Surgery, and Others. Based on End User, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Surgical Drill, Surgical Saw, Accessories, Power Source, and Reamer. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Surgical Power Tools Market will Hit $2.8 Billion by 2028, at a CAGR of 4.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Arthrex, Inc., B. Braun Melsungen AG (Aesculap, Inc.), ConMed Corporation, Johnson & Johnson, Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., Nouvag AG, American Precision Industries, Inc. (Altra Industrial Motion Corp.), and GPC Medical Ltd.
By Technology
By Application
By End User
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
